| Device |
point of care hiv serology diagnostic and/or supplemental test |
| Regulation Description |
Human immunodeficiency virus (HIV) serological diagnostic and/or supplemental test. |
| Definition |
Human immunodeficiency virus (HIV) Point of Care serological diagnostic and supplemental tests are prescription devices for the qualitative detection of HIV antigen(s) and/or detection of antibodies against HIV in human body fluids or tissues. |
| Physical State |
Lateral flow, membrane, manual, automated reader, swab, lancet, capillary |
| Technical Method |
Antibody/antigen, elisa, chemiluminescence, manual |
| Target Area |
Whole blood, plasma, serum, oral fluid, capillary blood, venous blood |
| Regulation Medical Specialty |
Microbiology |
| Review Panel |
Microbiology |
| Product Code | QSU |
| Premarket Review |
Center for Biologics Evaluation & Research (CBER)
|
| Submission Type |
510(k)
|
| Regulation Number |
866.3956
|
| Device Class |
2
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
| Implanted Device? |
No
|
| Life-Sustain/Support Device? |
No
|
| Third Party Review |
Not Third Party Eligible |
|
|